biote Corp. (BTMD) stock

BTMDNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 4/30

$1.06+0.03 (+3.40%)

Close on Nov 13, 2026Market cap $38.26MP/E –Yield –

biote r&d expenses

Research and development expenses are spending on new products and technology.

biote has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is BTMD.

Revenue growth-8.6% · median -6.6%

Gross margin67.5% · median 44.0%

Operating margin5.0% · median 1.5%

Net margin-1.1% · median 0.6%

Advertisement
300 × 250

See a number that looks wrong?